Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Sep;56(9):2440-2449.
doi: 10.1161/STROKEAHA.125.050993. Epub 2025 Jun 25.

Thrombectomy Versus Medical Management for Pediatric Arterial Ischemic Stroke With Large Baseline Infarct

Affiliations
Comparative Study

Thrombectomy Versus Medical Management for Pediatric Arterial Ischemic Stroke With Large Baseline Infarct

Kartik D Bhatia et al. Stroke. 2025 Sep.

Abstract

Background: Multiple recent randomized trials have demonstrated the benefit of thrombectomy over medical management alone in adult patients with large vessel occlusion (LVO) stroke and large infarct on baseline imaging. Cohort studies have also identified improved functional outcomes in pediatric patients who received thrombectomy. However, the role of thrombectomy in pediatric stroke with large baseline infarct remains uncertain.

Methods: A case-control study was undertaken using pooled data from 3 cohort studies of pediatric stroke (Save ChildS [Safety and Outcome of Endovascular Recenalization in Childhood Stroke Study], Save ChildS Pro [Safety and Outcome of Endovascular Recenalization in Childhood Stroke Prospective Registry], Pediatric LVO Stroke Study). Pediatric patients of age 1 to 18 years with acute anterior circulation LVO stroke presenting within 24 hours since last seen well with an Alberta Stroke Program Early CT Score of 0 to 5 on CT or magnetic resonance imaging were included. Isolated M2 occlusion or focal cerebral arteriopathy-inflammatory subtype cases were excluded. Thrombectomy-treated patients were compared with patients who received medical management alone. The primary clinical outcome was the pediatric modified Rankin Scale score at 90 days, compared between groups using ordinal logistic regression.

Results: Of 56 pediatric patients with anterior circulation LVO and low Alberta Stroke Program Early CT Score presenting between January 1, 2000 and August 31, 2023 from 45 centers across Europe, North America, and Australia, 40 patients were eligible for inclusion (female: n=14, 35.0%; mean age, 9.1 years; range, 1.5-17; SD, 5.27). Thrombectomy-treated patients (n=24) had significantly better pediatric modified Rankin Scale scores at 90 days than medical management alone patients (n=16; odds ratio, 3.68 [95% CI, 1.11-12.21]; P=0.034). There was no significant difference between groups in the rate of symptomatic intracranial hemorrhage (P=0.806).

Conclusions: In this multicentre case-control study, pediatric patients (age, 1-18 years) with anterior circulation LVO stroke and low Alberta Stroke Program Early CT Score who received thrombectomy had significantly better functional outcomes than those treated with medical management alone. Exclusion of pediatric patients from thrombectomy based on low Alberta Stroke Program Early CT Score alone may not be appropriate.

Keywords: case-control studies; child; intracranial hemorrhage; stroke; thrombectomy.

PubMed Disclaimer

Conflict of interest statement

R.C. Dale reports compensation from Roche for data and safety monitoring services. Dr Fox reports grants from National Institutes of Health; grants from National Institutes of Health; grants from Pediatric Epilepsy Research Foundation; employment by University of California San Francisco; and Pediatric stroke topics for UpToDate Author. Dr Fiehler reports compensation from Medtronic USA Inc for consultant services; compensation from Penumbra Inc for consultant services; compensation from TG Medical for consultant services; stock holdings in Tegus Medical; stock holdings in Vastrax; compensation from Cerenovus for consultant services; compensation from MicroVention Inc for consultant services; compensation from Roche for consultant services; employment by Eppdata; compensation from Tonbridge for consultant services; stock holdings in Eppdata; compensation from Phenox for consultant services; stock holdings in Eppdata; compensation from Stryker Corporation for consultant services; and compensation from Acandis for consultant services. Dr Sun reports compensation from Inozyme Pharmaceuticals, Inc, for consultant services and grants from the American Heart Association. Dr Sporns reports grants from Novartis Stiftung für Medizinisch-Biologische Forschung. The other authors report no conflicts.